Phase II trial of preoperative S-1 plus cisplatin followed by surgery for initially unresectable locally advanced gastric cancer
- 1 February 2012
- journal article
- research article
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 38 (2) , 143-149
- https://doi.org/10.1016/j.ejso.2011.11.009
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cancer Incidence and Incidence Rates in Japan in 2003: Based on Data from 13 Population-based Cancer Registries in the Monitoring of Cancer Incidence in Japan (MCIJ) ProjectJapanese Journal of Clinical Oncology, 2009
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trialThe Lancet Oncology, 2008
- Survival of Cancer Patients Diagnosed between 1993 and 1996: a Collaborative Study of Population-Based Cancer Registries in JapanJapanese Journal of Clinical Oncology, 2006
- Phase I/II study of S-1 combined with cisplatin in patients with advanced gastric cancerBritish Journal of Cancer, 2003
- Phase II study of sequential high-dose methotrexate and fluorouracil combined with doxorubicin as a neoadjuvant chemotherapy for scirrhous gastric cancerGastric Cancer, 2001
- Estimating the world cancer burden: Globocan 2000International Journal of Cancer, 2001
- New Guidelines to Evaluate the Response to Treatment in Solid TumorsJNCI Journal of the National Cancer Institute, 2000
- An Early Phase II Study of Oral S-1, a Newly Developed 5-Fluorouracil Derivative for Advanced and Recurrent Gastrointestinal CancersOncology, 1999
- Japanese Classification of Gastric Carcinoma – 2nd English Edition –Gastric Cancer, 1998
- Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1M tegafur–0.4M gimestat–1M otastat potassium) in advanced gastric cancer patientsEuropean Journal Of Cancer, 1998